Login / Signup

Comparative test-retest variability of outcome parameters derived from brain [18F]FDG PET studies in non-human primates.

Sébastien GoutalNicolas TournierMartine GuillermierNadja Van CampOlivier BarretMylène GaudinMichel BottlaenderPhilippe HantrayeSonia Lavisse
Published in: PloS one (2020)
[18F]FDG test-retest studies in NHP protocols need to be conducted under well-standardized experimental conditions to assess and select the most reliable and reproducible quantification approach. Furthermore, the choice of the quantification parameter has to account for the transversal or follow-up study design. If pons and cerebellum regions are not affected, non-invasive SUVR is the most favorable approach for both designs.
Keyphrases
  • pet ct
  • pet imaging
  • positron emission tomography
  • case control
  • endothelial cells
  • computed tomography
  • pluripotent stem cells
  • cerebral ischemia
  • subarachnoid hemorrhage
  • blood brain barrier
  • brain injury